Microsoft Research has unveiled Quine, an experimental system that treats biology as something a machine can model and then question. The team describes it as a multimodal world model built for the tangled, interconnected data of living systems.
Quine is more than a model. It is a harness that links foundation models, laboratory tools, published literature and working scientists into a single loop, so a hypothesis can travel from reading to experiment without switching systems. Microsoft developed the effort with researchers at the Broad Institute of Harvard and MIT.
The collaboration stress-tested Quine on drug discovery. The system ranked compounds by their predicted ability to push tumor cells toward a treatable state, and several top-ranked candidates held up across multiple wet-lab assays. That is a signal the model is ranking real biology rather than fitting text.
Microsoft also opened a Quine Fellows program, giving a cohort of scientists direct access to the system and a route to feed back what works.
The company is careful about limits. Quine is research technology, not a clinical tool, and its outputs can be incomplete or wrong until qualified researchers validate them with experiments.
As the system matures, Microsoft expects to widen access through commercial products such as Microsoft Discovery.
